Skip to main content
Veterinary Medicines

Uristop 40 mg/ml syrup for dogs

Authorised
  • Phenylpropanolamine hydrochloride

Product identification

Medicine name:
Uristop 40 mg/ml syrup for dogs
URIXINE 40,28 MG/ML SIROP POUR CHIENS
Active substance:
  • Phenylpropanolamine hydrochloride
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Phenylpropanolamine hydrochloride
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Syrup
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG04BX91
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:
  • Box with 1 bottle of 100 ml and 1 syringe of 1,5 ml
  • Box with 1 bottle of 50 ml and 1 syringe of 1,5 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Karizoo S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Fatro S.p.A.
  • Laboratorios Karizoo S.A.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/5100093 2/2024
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0288/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Estonia
  • France
  • Germany
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 27/06/2024
Download
French (PDF)
Published on: 2/07/2024

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 2/07/2024

eu-PUAR-esv0288001-mrp-uristop-40-mg-ml-syrup-for-dogs-en.pdf

English (PDF)
Published on: 24/07/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."